164989-45-1

Basic information

• Product Name: 2-azido-1-O-(2,3,4,6-tetra-O-benzyl-α-D-galactopyranosyl)octadecanol
• Synonyms: 2-azido-1-O-(2,3,4,6-tetra-O-benzyl-α-D-galactopyranosyl)octadecanol
• CAS NO: 164989-45-1
• Molecular Weight: 834.152
• Mol File: 164989-45-1.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 2-azido-1-O-(2,3,4,6-tetra-O-benzyl-α-D-galactopyranosyl)octadecanol(CAS DataBase Reference)
• NIST Chemistry Reference: 2-azido-1-O-(2,3,4,6-tetra-O-benzyl-α-D-galactopyranosyl)octadecanol(164989-45-1)
• EPA Substance Registry System: 2-azido-1-O-(2,3,4,6-tetra-O-benzyl-α-D-galactopyranosyl)octadecanol(164989-45-1)

Safety Data

• Hazardous Substances Data: 164989-45-1(Hazardous Substances Data)

Upstream product

• 164989-42-8 2-O-(methylsulfonyl)-1-O-(triphenylmethyl)-1,2-octadecanediol 
• 88875-77-8 1-O-(triphenylmethyl)-1,2-octadecanediol 
• 115563-43-4 (2S,3S,4R)-2,3,5-tribenzyloxy-4-hydroxypentanal 
• 4762-26-9 hexyltriphenylphosphonium bromide 
• 20672-66-6 3,4,5-tri-O-benzyl-D-galactopyranose 
• 111-25-1 1-bromo-hexane 
• 20294-76-2 rac-1,2-dihydroxyoctadecane 
• 7390-81-0 2-hexadecyloxirane 
• 164989-43-9 2-azido-1-O-(triphenylmethyl)octadecanol 
• 164988-61-8 (2R,3S,4R)-1,3,4-tri-O-benzyl-1,2,3,4-undecanetetrol 

Downstream Products

• 164989-47-3 1-O-(2,3,4,6-tetra-O-benzyl-α-D-galactopyranosyl)-2-(N-tetracosanoylamino)octadecanol 
• 164989-46-2 1-((2S,3R,4S,5S,6R)-3,4,5-Tris-benzyloxy-6-benzyloxymethyl-tetrahydro-pyran-2-yloxymethyl)-heptadecylamine 

Relevant articles and documents

Structure-activity relationship of α-galactosylceramides against b16- bearing mice

Agelasphin-9b, (2S,3S,4R)-1-O-(α-D-galactopyranosyl)-16-methyl-2-[N- ((R)-2-hydroxytetracosanoyl)-amino]-1,3,4-heptadecanetriol, is a potent antitumor agent isolated from the marine sponge Agelas mauritianus. Various analogues of agelasphin-9b (a lead compound) were synthesized, and the relationship between their structures and biological activities was examined using several assay systems. From the results, KRN7000, (2S,3S,4R)-1-O-(α- D-galactopyranosyl)-2-(N-hexacosanoylamino)-1,3,4-octadecanetriol, was selected as a candidate for clinical application.